Suchergebnisse - "Moreno, Lucas"

PubPharm (8)

1

Structural disruption of BAF chromatin remodeller impairs neuroblastoma metastasis by reverting an invasiveness epigenomic program

enthalten in: Molecular cancer | 2022

von Jiménez, C. | Antonelli, R. | Nadal-Ribelles, M. | +14

2

Structural disruption of BAF chromatin remodeller impairs neuroblastoma metastasis by reverting an invasiveness epigenomic program

enthalten in: Molecular cancer | 2022

von Jiménez, C. | Antonelli, R. | Nadal-Ribelles, M. | +14

3

Structural disruption of BAF chromatin remodeller impairs neuroblastoma metastasis by reverting an invasiveness epigenomic program

enthalten in: Molecular cancer | 2022

von Jiménez, C. | Antonelli, R. | Nadal-Ribelles, M. | +14

4

Accelerating drug development for neuroblastoma : Summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma

enthalten in: European journal of cancer (Oxford, England : 1990) | 2020

von Moreno, L. | Barone, G. | DuBois, S. | +35

5

Phase II results from a phase I/II study to assess the safety and efficacy of weekly nab-paclitaxel in paediatric patients with recurrent or refractory solid tumours : A collaboration with the European Innovative Therapies for Children with Cancer Network

enthalten in: European journal of cancer (Oxford, England : 1990) | 2020

von Amoroso, L. | Castel, V. | Bisogno, G. | +15

6

Phase I results of a phase I/II study of weekly nab-paclitaxel in paediatric patients with recurrent/refractory solid tumours : A collaboration with innovative therapies for children with cancer

enthalten in: European journal of cancer (Oxford, England : 1990) | 2018

von Moreno, L. | Casanova, M. | Chisholm, J. | +20

7

Accelerating drug development for neuroblastoma - New Drug Development Strategy : an Innovative Therapies for Children with Cancer, European Network for Cancer Research in Children and Adolescents and International Society of Paediatric Oncology Europe Neuroblastoma project

enthalten in: Expert opinion on drug discovery | 2017

von Moreno, L. | Caron, H. | Geoerger, B. | +26

8

Novel pharmacodynamic biomarkers for MYCN protein and PI3K/AKT/mTOR pathway signaling in children with neuroblastoma

enthalten in: Molecular oncology | 2016

von Smith, J. | Moreno, L. | Heaton, S. | +3

1
[1]